Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Prescient Therapeutics Limited ( (AU:PTX) ) is now available.
Prescient Therapeutics Limited has announced its Annual General Meeting (AGM) scheduled for October 14, 2025, to be held as a hybrid event, allowing shareholders to attend either in person or virtually. This approach aims to enhance shareholder engagement by enabling participation through online platforms, where attendees can ask questions and vote on resolutions, reflecting the company’s commitment to transparency and inclusivity.
More about Prescient Therapeutics Limited
Prescient Therapeutics Limited operates in the biotechnology industry, focusing on developing innovative cancer therapies. The company is dedicated to advancing targeted and personalized medicine to improve treatment outcomes for cancer patients.
Average Trading Volume: 1,255,143
Technical Sentiment Signal: Sell
Current Market Cap: A$43.64M
See more data about PTX stock on TipRanks’ Stock Analysis page.